Lack of Synergistic Outcomes with Roflumilast Combined with Levetiracetam or Adipose Stem Cell Secretome After Spinal Cord Injury
Carla S. Sousa, Rui Lima, Eduardo D. Gomes, Deolinda Silva, Jorge Ribeiro Cibrão, Tiffany S. Pinho, Diogo Jorge, João Afonso, Joana Martins‐Macedo, Andreia Monteiro, António José Salgado, Nuno A. Silva
This study evaluates the synergistic effects of Roflumilast combined with Levetiracetam or Adipose Stem Cell secretome after spinal cord injury, finding no improvement in functional outcomes compared to single treatments.
bioRxiv · Jul 2, 2024 · PreprintNeuroscience